PearlRiver Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • M&A

PearlRiver Bio General Information

Description

Operator of a biotechnology company intended to discover inhibitors to target cancer with oncogenic mutations. The company is developing potent and selective oral exon20 insertion mutation inhibitors intended to have minimal activity on wild-type EGFR and optimal pharmacokinetic properties, for the treatment of EGFR exon20 insertions, enabling researchers to find a cure for cancer by targetting non-small lung cancer cell.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Otto-Hahn-Straße 15
  • 44227 Dortmund
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Otto-Hahn-Straße 15
  • 44227 Dortmund
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PearlRiver Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 16-Feb-2021 Completed Generating Revenue
1. Early Stage VC 29-Mar-2019 Completed Startup
To view PearlRiver Bio’s complete valuation and funding history, request access »

PearlRiver Bio Patents

PearlRiver Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3868759-A1 2,3,5-substituted pyrrolo[2,3-b]pyridines as erbb modulators useful for treating cancer Inactive 20-Feb-2020
EP-3868760-A1 2,3,5-substituted pyrrolo[2,3-b]pyridines as erbb modulators useful for treating cancer Inactive 20-Feb-2020
WO-2021165469-A1 2,3,5-substituted pyrrolo[2,3-b]pyridines as erbb modulators useful for treating cancer Inactive 20-Feb-2020
WO-2021165497-A1 2,3,5-substituted pyrrolo[2,3-b]pyridines as erbb modulators useful for treating cancer Inactive 20-Feb-2020 C07D471/04

PearlRiver Bio FAQs

  • When was PearlRiver Bio founded?

    PearlRiver Bio was founded in 2019.

  • Where is PearlRiver Bio headquartered?

    PearlRiver Bio is headquartered in Dortmund, Germany.

  • What industry is PearlRiver Bio in?

    PearlRiver Bio’s primary industry is Drug Discovery.

  • Is PearlRiver Bio a private or public company?

    PearlRiver Bio is a Private company.

  • What is PearlRiver Bio’s current revenue?

    The current revenue for PearlRiver Bio is .

  • How much funding has PearlRiver Bio raised over time?

    PearlRiver Bio has raised $66.5K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process